Navigation Links
Longs Drug Stores Corporation Reports Second Quarter Results
Date:8/20/2008

/p>

Retail drug store operating income was $31.6 million, or 2.6 percent of retail drug store sales, compared with $33.4 million, or 2.8 percent of sales last year. Pharmacy benefit services operating income was $14.9 million, or 11.4 percent of pharmacy benefit services revenues, compared with $10.9 million, or 13.8 percent of pharmacy benefit services revenues last year.

First Six Months

Income

Income from continuing operations for the 26 weeks ended July 31, 2008 was $50.6 million, or $1.40 per diluted share, compared with income from continuing operations for the 26 weeks ended July 26, 2007 of $41.8 million, or $1.09 per diluted share, including $5.8 million of after-tax charges related to the disposition of stores.

Revenues

Total revenues of $2.74 billion for the 26 weeks ended July 31, 2008 were 6.5 percent higher than the $2.57 billion reported for the 26 weeks ended July 26, 2007.

Retail drug store sales increased 1.7 percent to $2.42 billion from $2.38 billion in the comparable period last year. Same-store sales decreased 0.1 percent with pharmacy same-store sales flat with last year and front-end same- store sales decreasing 0.1 percent. Pharmacy sales were 52.0 percent of retail drug store sales during the period, compared with 51.8 percent a year ago.

Pharmacy benefit services revenues increased 66.8 percent to $318.6 million from $191.0 million in the comparable period last year. Prescription drug plan revenues were $278.0 million compared with $162.2 million last year and pharmacy benefit management revenues were $40.6 million compared with $28.7 million a year ago.

Retail Drug Store Gross Profit

Retail drug store gross profit for the 26 weeks ended July 31, 2008 was $645.4 million, or 26.7 percent of retail drug store sales, compared with $618.4 million, or 26.0 percent of retail drug store sales, last year. The increase in gross profit as a percent of sales was primarily due to higher
'/>"/>

SOURCE Longs Drug Stores Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
2. Longs Reports Preliminary June Retail Drug Store Sales
3. Longs Drug Stores to Continue to Service Medi-Cal Patients
4. Radiation therapy prolongs life in men with recurrent prostate cancer
5. Longs Reports Preliminary May Retail Drug Store Sales
6. Golf prolongs life
7. Longs Drug Stores Corporation Announced at Its Annual Meeting of Stockholders
8. Longs Drug Stores Donates Supplies to Victims of Santa Cruz Mountain Fires
9. Longs Drugs Partners With Google on the Launch of Google Health
10. Longs Reports Preliminary March Retail Drug Store Sales
11. Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...wswire-FirstCall/ -- Care Investment Trust Inc. ...ounced that its Board of Directors has declared a ...dividend is payable on December 22, 2009 to common..., About Care Investment Trust ,, Care Inve...finance company investing in healthcare-related re...
(Date:12/4/2009)...Newswire-USNewswire/ -- The American Association o...s the Senate for ensuring that the Community Livi...in in the final health reform legislation . The CL... to elders, people with disabilities and their car...h care reform bill that will make it affordable to...
(Date:12/4/2009)...c. 4 Pamela Bowen, Chief Informati... a finalist for the "Chief Innovation Officer" App...the power of cloud computing. Appy Award recipient... Salesforce CRM or the Force.com platform in bring... marketing, partner, service, support or IT organi...
(Date:12/4/2009)... study shows that muscle cells grown in the lab ca...roperly. The work, performed in dogs and rats, mig...such as gastric reflux and fecal incontinence. , ...rs, which are the bands of muscle that separate th...s in these areas can cause gastrointestinal esopha...
(Date:12/4/2009)... men can be bastards and women must wear pearls an...swer, according to an article in the Journal of V...pressions. , In two studies, researchers asked s...In the first study, androgynous faces with lowered...more likely to be identified as male, and faces wi...
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2
...n Experts Applaud This Good-For-You Treat in Disgu...t the heart,of the Halloween fun. But it,s easy fo...t being booed by the kids. Nutrition experts recom...e chocolaty taste that witches, ghosts and superhe...
...ON, Oct. 4 Health information,technology (HIT) is...-term,care, but it must be implemented to interact...successful, according to a new report by,BearingPo...n by The New School in New York. The report examin...
...ent Purchase for Installation in United Kingdom, ...asdaq: ARAY ), a global leader in the field of ra... services company, Hospital,Corporation of America...st non-U.S. CyberKnife System purchase. "CyberKni...
...RIDGE, N.J., Oct. 4 Hooper Holmes,(Amex: HH ) to...aining,program for all paramedical examiners who h...any. The proprietary, computer-based training syst...ortamedic locations nationwide. Portamedic is the...
... lengthen the time needed between tests, researche...ared to conventional tests, human papillomavirus (...ons that lead to cervical cancer, Dutch researcher...ore than 17,000 women ages 29 to 56. Of those, clo...
...resented This Week at Major Medical Meeting Reinfo...ococcal Vaccines -, COLLEGEVILLE, Pa., Oct. 4 Wy...YE ), comments on studies to be,presented this wee...theria CRM197 Protein]), a vaccine which helps to,...
Other Medicine News:Health News:Chocolate Milk: 'The Official Drink of Halloween' 2Health News:Chocolate Milk: 'The Official Drink of Halloween' 3Health News:Chocolate Milk: 'The Official Drink of Halloween' 4Health News:New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care 2Health News:New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care 3Health News:New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care 4Health News:Hospital Corporation of America Purchases Seventh CyberKnife(R) System 2Health News:Hospital Corporation of America Purchases Seventh CyberKnife(R) System 3Health News:Hospital Corporation of America Purchases Seventh CyberKnife(R) System 4Health News:Portamedic Launches New Examiner Training Program 2Health News:Portamedic Launches New Examiner Training Program 3Health News:Gene-Based Screen Spots Cervical Cancer Earlier 2Health News:Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease 2Health News:Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease 3Health News:Wyeth Comments on PREVNAR and Trends in Pneumococcal Disease 4
(Date:12/3/2009)...s., Dec. 3 Allen Medical...(NYSE: HRC ), today announced the launch of its ...facturer) business website www.AllenAmatech.com ...(TM) brand identity and includes an online version...tions and design specifications for the products. ...
(Date:12/3/2009)...TOWN, Pa., Dec. 3 Ted Ka... (Nasdaq: QGLY ) www.quigleyco.com announced to...of its opportunities to develop prescription pharm...it is in its best interests to focus primarily on ...de but are not limited to its Cold-EEZE® and ...
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
Breaking Medicine Technology:Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Prominent Farmington Hills Plastic Surgeon Suggests Methods to Repair Skin Damaged by Sun Exposure 47483 1John Hancock Launches New Retirement Income Solution 47481 1John Hancock Launches New Retirement Income Solution 47481 2John Hancock Launches New Retirement Income Solution 47481 3John Hancock Launches New Retirement Income Solution 47481 4John Hancock Launches New Retirement Income Solution 47481 5Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 1Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 2Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 3Video 3A truth 28R 29 Asks 3A Do You Have What it Takes 3F 47479 4
...mpany Planning to Initiate Phase 2 Trials in Color...ncer in Q307 -, SOUTH SAN FRANCISCO, Calif., June ...euticals, Inc. , a,biopharmaceutical company focus...from an interim safety analysis of two Phase 1,dos...n platinum for,the potential first-line treatment ...
...RÉAL, June 1, 2007 – Thallion Pharmac...iminary data from its Phase,I/II clinical trial in...as published in abstract form as part of the Ameri...ting in Chicago,Illinois. In the Phase I dose esc...orectal, two ovarian, one duodenal and one,glioma)...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3
Seattle Small Joint Arthroscopy Cup Currette
ECTRA II System without Endoscope
ECTRA II System 25 mm
AZTEC Shoulder Holder and MITT
Medicine Products: